Within our TB cohort, TB therapy reduced CTLA-4 expression on PPD-specific CD4 T-cells by 60% (p = 0.0025) while only a trend towards reduced PD-1 expression was observed (33.4% vs. 20.9%, p = 0.25, Fig 3B). This evidence concerns the gene CD4 and tuberculosis.